目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 INCLUSIONS AND EXCLUSIONS
1.3.2 MARKETS COVERED
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
2.5.1 METHODOLOGY-RELATED LIMITATIONS
2.5.2 SCOPE-RELATED LIMITATIONS
2.6 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PHYSIOTHERAPY EQUIPMENT MARKET
4.2 ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER AND COUNTRY
4.3 PHYSIOTHERAPY EQUIPMENT MARKET, BY KEY COUNTRIES
4.4 PHYSIOTHERAPY EQUIPMENT MARKET, BY REGION
4.5 PHYSIOTHERAPY EQUIPMENT MARKET: DEVELOPED VS. EMERGING MARKETS

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rapidly growing geriatric population and increasing instances of chronic diseases
5.2.1.2 Growing incidence of sports injuries, degenerative joint disorders, and cerebrovascular diseases
5.2.1.3 Rising demand for rehabilitation care
5.2.1.4 Growing demand for home-based and telerehabilitation care
5.2.2 RESTRAINTS
5.2.2.1 Unstable reimbursement scenario for physiotherapy
5.2.2.2 Issue in direct access to physiotherapy
5.2.3 OPPORTUNITIES
5.2.3.1 Large population in emerging economies
5.2.3.2 Technological advancements
5.2.4 CHALLENGES
5.2.4.1 Shortage of skilled personnel
5.2.4.2 Acupuncture and other alternative therapies
5.3 PORTER'S FIVE FORCES ANALYSIS
5.3.1 THREAT OF NEW ENTRANTS
5.3.2 THREAT OF SUBSTITUTES
5.3.3 BARGAINING POWER OF SUPPLIERS
5.3.4 BARGAINING POWER OF BUYERS
5.3.5 INTENSITY OF COMPETITIVE RIVALRY
5.4 INDUSTRY TRENDS
5.4.1 INTEGRATION OF INTERNET OF THINGS IN PHYSIOTHERAPY EQUIPMENT
5.4.2 TECHNOLOGICAL ADVANCEMENTS IN PHYSIOTHERAPY EQUIPMENT
5.5 VALUE CHAIN ANALYSIS
5.6 TECHNOLOGY ANALYSIS
5.6.1 KEY TECHNOLOGIES
5.6.1.1 Robotic instruments
5.6.1.2 Artificial intelligence and machine learning
5.6.1.3 Virtual physiotherapy
5.6.2 COMPLEMENTARY TECHNOLOGIES
5.6.2.1 Augmented reality
5.6.3 ADJACENT TECHNOLOGIES
5.6.3.1 Wearable sensors
5.7 REGULATORY LANDSCAPE
5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7.2 REGULATORY FRAMEWORK
5.7.2.1 North America
5.7.2.1.1 US
5.7.2.1.2 Canada
5.7.2.2 Europe
5.7.2.3 Asia Pacific
5.7.2.3.1 Japan
5.7.2.3.2 China
5.7.2.3.3 India
5.8 PATENT ANALYSIS
5.8.1 PATENT PUBLICATION TRENDS FOR PHYSIOTHERAPY EQUIPMENT
5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.9 TRADE ANALYSIS
5.10 PRICING ANALYSIS
5.11 KEY CONFERENCES AND EVENTS DURING 2024-2025
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.12.2 BUYING CRITERIA
5.13 END USER EXPECTATIONS IN PHYSIOTHERAPY EQUIPMENT MARKET
5.14 ADJACENT MARKET ANALYSIS
5.15 ECOSYSTEM ANALYSIS
5.16 CASE STUDY ANALYSIS
5.16.1 CASE STUDY 1: STARTOON LABS RECEIVED USFDA APPROVAL FOR PHEEZEE PHYSIOTHERAPY DEVICE
5.16.2 CASE STUDY 2: UKNHS TO LAUNCH AI-DRIVEN PHYSIOTHERAPY CLINIC
5.16.3 CASE STUDY 3: BURJEEL AND LEEJAM LAUNCHED PHYSIOTHERABIA IN RIYADH
5.17 SUPPLY CHAIN ANALYSIS
5.18 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.19 INVESTMENT AND FUNDING SCENARIO
5.20 REIMBURSEMENT SCENARIO
5.21 IMPACT OF GENERATIVE AI ON PHYSIOTHERAPY EQUIPMENT MARKET

6 PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 EQUIPMENT
6.2.1 ELECTROTHERAPY EQUIPMENT
6.2.1.1 Neuromuscular electrical stimulation and therapeutic electrical stimulation to be used in rehabilitation settings
6.2.2 ULTRASOUND EQUIPMENT
6.2.2.1 Ultrasound equipment to have major applications in connective tissue therapies
6.2.3 EXERCISE THERAPY EQUIPMENT
6.2.3.1 Awareness of advantages of therapeutic exercises to drive segmental growth
6.2.4 HEAT THERAPY EQUIPMENT
6.2.4.1 Heat therapy recognized as leading treatment for arthritis
6.2.5 CRYOTHERAPY EQUIPMENT
6.2.5.1 Rising popularity of wellness and fitness to drive segmental growth
6.2.6 COMBINATION THERAPY EQUIPMENT
6.2.6.1 Wide application across different patient population to drive segmental growth
6.2.7 CONTINUOUS PASSIVE MOTION THERAPY EQUIPMENT
6.2.7.1 Increasing number of reconstructive joint surgeries to drive segmental growth
6.2.8 SHOCKWAVE THERAPY EQUIPMENT
6.2.8.1 Non-surgical therapy used to treat various indications causing acute or chronic pain
6.2.9 LASER THERAPY EQUIPMENT
6.2.9.1 Versatile tool used for physical therapy
6.2.10 TRACTION THERAPY EQUIPMENT
6.2.10.1 Growing cases of non-traumatic spinal cord injuries to drive demand
6.2.11 MAGNETIC PRESSURE THERAPY EQUIPMENT
6.2.11.1 Therapeutic effectiveness of magnetotherapy to be lower than other physical therapies
6.2.12 OTHER PHYSIOTHERAPY EQUIPMENT
6.3 ACCESSORIES
6.3.1 PHYSIOTHERAPY FURNITURE
6.3.1.1 Used for physical therapy, rehab, occupational therapy, sports medicine, and chiropractic medicine
6.3.2 OTHER ACCESSORIES

7 PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 MUSCULOSKELETAL
7.2.1 RISING INCIDENCE OF MUSCULOSKELETAL DISORDERS TO DRIVE GROWTH
7.3 NEUROLOGICAL
7.3.1 INCREASING INCIDENCE OF NEUROLOGICAL DISORDERS TO DRIVE GROWTH
7.4 CARDIOVASCULAR & PULMONARY
7.4.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES TO DRIVE GROWTH
7.5 PEDIATRIC
7.5.1 PEDIATRIC PHYSIOTHERAPY TO PROMOTE ACTIVITY AND PARTICIPATION IN EVERYDAY ROUTINES
7.6 GYNECOLOGICAL
7.6.1 GYNECOLOGICAL SEGMENT TO BE FASTEST-GROWING APPLICATION DURING FORECAST PERIOD
7.7 OTHER APPLICATIONS

8 PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER
8.1 INTRODUCTION
8.2 PHYSIOTHERAPY & REHABILITATION CENTERS
8.2.1 RISING INCIDENCE OF SPORTS INJURIES AND DISABILITIES TO DRIVE SEGMENTAL GROWTH
8.3 HOSPITALS
8.3.1 GROWING PATIENT VOLUMES AT HOSPITALS TO DRIVE SEGMENTAL GROWTH
8.4 HOME CARE SETTINGS
8.4.1 RISING DEMAND FOR HOME CARE TO DRIVE SEGMENTAL GROWTH
8.5 PHYSICIANS' OFFICES
8.5.1 FIRST POINT OF CONTACT FOR MANAGEMENT OF HEALTH PROBLEMS
8.6 OTHER END USERS

9 PHYSIOTHERAPY EQUIPMENT MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 MACROECONOMIC OUTLOOK
9.2.2 US
9.2.2.1 To dominate North American market during forecast period
9.2.3 CANADA
9.2.3.1 Growing penetration of preventive care services to boost market
9.3 EUROPE
9.3.1 MACROECONOMIC OUTLOOK
9.3.2 GERMANY
9.3.2.1 Rising geriatric population and increase in chronic conditions to drive demand
9.3.3 UK
9.3.3.1 Wide acceptance of physical therapy to increase adoption of physiotherapy equipment
9.3.4 FRANCE
9.3.4.1 Rising healthcare expenditure and favorable reimbursement scenario to drive market
9.3.5 ITALY
9.3.5.1 Increasing incidence of fall injuries and orthopedic disorders to drive market
9.3.6 SPAIN
9.3.6.1 Rising geriatric population to drive adoption of physiotherapy equipment
9.3.7 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 MACROECONOMIC OUTLOOK
9.4.2 JAPAN
9.4.2.1 Large geriatric population to drive adoption of physiotherapy equipment
9.4.3 CHINA
9.4.3.1 Fitness plans by government to drive market
9.4.4 INDIA
9.4.4.1 Expansion of new acute care settings to drive demand
9.4.5 AUSTRALIA
9.4.5.1 Growing population and rising cases of chronic musculoskeletal conditions to drive market
9.4.6 SOUTH KOREA
9.4.6.1 Fast-growing aging population and rising medical tourism to drive market
9.4.7 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 MACROECONOMIC OUTLOOK
9.5.2 BRAZIL
9.5.2.1 Rapidly aging population and expanding healthcare infrastructure to augment market growth
9.5.3 MEXICO
9.5.3.1 High prevalence rates of chronic conditions to drive market
9.5.4 ARGENTINA
9.5.4.1 Advancements in healthcare infrastructure to drive market
9.5.5 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 MACROECONOMIC OUTLOOK
9.6.2 GCC COUNTRIES
9.6.2.1 ROBUST HEALTHCARE INDUSTRY TO DRIVE MARKET
9.6.3 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 STRATEGIES ADOPTED BY KEY PLAYERS
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
10.4 MARKET SHARE ANALYSIS
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
10.5.5.1 Company footprint
10.5.5.2 Region footprint
10.5.5.3 Product footprint
10.5.5.4 Application footprint
10.5.5.5 End user footprint
10.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
10.6.1 PROGRESSIVE COMPANIES
10.6.2 RESPONSIVE COMPANIES
10.6.3 DYNAMIC COMPANIES
10.6.4 STARTING BLOCKS
10.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023
10.7 COMPETITIVE SCENARIO
10.7.1 PRODUCT LAUNCHES AND APPROVALS
10.7.2 DEALS
10.7.3 EXPANSIONS
10.7.4 OTHER DEVELOPMENTS
10.8 BRAND/PRODUCT COMPARISON
10.9 R&D ASSESSMENT OF KEY PLAYERS
10.10 COMPANY VALUATION AND FINANCIAL METRICS
10.10.1 FINANCIAL METRICS
10.10.2 COMPANY VALUATION

11 COMPANY PROFILES
11.1 KEY PLAYERS
11.1.1 ENOVIS (FORMERLY COLFAX)
11.1.1.1 Business overview
11.1.1.2 Products offered
11.1.1.3 Recent developments
11.1.1.3.1 Product launches
11.1.1.3.2 Deals
11.1.1.3.3 Expansions
11.1.1.3.4 Other developments
11.1.1.4 MnM view
11.1.1.4.1 Right to win
11.1.1.4.2 Strategic choices
11.1.1.4.3 Weaknesses & competitive threats
11.1.2 ZIMMER MEDIZINSYSTEME GMBH
11.1.2.1 Business overview
11.1.2.2 Products offered
11.1.2.3 Recent developments
11.1.2.3.1 Product launches
11.1.2.3.2 Deals
11.1.2.3.3 Other developments
11.1.2.4 MnM view
11.1.2.4.1 Right to win
11.1.2.4.2 Strategic choices
11.1.2.4.3 Weaknesses & competitive threats
11.1.3 ZYNEX, INC.
11.1.3.1 Business overview
11.1.3.2 Products offered
11.1.3.3 Recent developments
11.1.3.3.1 Product launches and approvals
11.1.3.3.2 Deals
11.1.3.3.3 Expansions
11.1.3.3.4 Other developments
11.1.3.4 MnM view
11.1.3.4.1 Right to win
11.1.3.4.2 Strategic choices
11.1.3.4.3 Weaknesses & competitive threats
11.1.4 PERFORMANCE HEALTH (SUBSIDIARY OF MADISON DEARBORN PARTNERS)
11.1.4.1 Business overview
11.1.4.2 Products offered
11.1.4.3 Recent developments
11.1.4.3.1 Product launches
11.1.4.3.2 Deals
11.1.4.3.3 Other developments
11.1.4.4 MnM view
11.1.4.4.1 Right to win
11.1.4.4.2 Strategic choices
11.1.4.4.3 Weaknesses & competitive threats
11.1.5 ITO CO., LTD.
11.1.5.1 Business overview
11.1.5.2 Products offered
11.1.5.3 MnM view
11.1.5.3.1 Right to win
11.1.5.3.2 Strategic choices
11.1.5.3.3 Weaknesses & competitive threats
11.1.6 DYNATRONICS CORPORATION
11.1.6.1 Business overview
11.1.6.2 Products offered
11.1.6.3 Recent developments
11.1.6.3.1 Product launches
11.1.6.3.2 Deals
11.1.7 BTL INDUSTRIES
11.1.7.1 Business overview
11.1.7.2 Products offered
11.1.7.3 Recent developments
11.1.7.3.1 Deals
11.1.7.3.2 Expansions
11.1.7.3.3 Other developments
11.1.8 ENRAF-NONIUS B.V.
11.1.8.1 Business overview
11.1.8.2 Products offered
11.1.8.3 Recent developments
11.1.8.3.1 Deals
11.1.9 EMS PHYSIO LTD.
11.1.9.1 Business overview
11.1.9.2 Products offered
11.1.10 MECTRONIC MEDICALE
11.1.10.1 Business overview
11.1.10.2 Products offered
11.1.11 WHITEHALL MANUFACTURING
11.1.11.1 Business overview
11.1.11.2 Products offered
11.1.12 RICHMAR (SUBSIDIARY OF COMPASS HEALTH BRANDS)
11.1.12.1 Business overview
11.1.12.2 Products offered
11.1.12.3 Recent developments
11.1.12.3.1 Product launches
11.1.12.3.2 Deals
11.1.13 LIFE CARE SYSTEMS
11.1.13.1 Business overview
11.1.13.2 Products offered
11.1.14 STORZ MEDICAL AG
11.1.14.1 Business overview
11.1.14.2 Products offered
11.1.14.3 Recent developments
11.1.14.3.1 Product launches
11.1.14.3.2 Deals
11.1.14.3.3 Expansions
11.1.15 METTLER ELECTRONICS CORP.
11.1.15.1 Business overview
11.1.15.2 Products offered
11.1.16 ALGEOS
11.1.16.1 Business overview
11.1.16.2 Products offered
11.1.16.3 Recent developments
11.1.16.3.1 Deals
11.1.17 GYMNA INTERNATIONAL
11.1.17.1 Business overview
11.1.17.2 Products offered
11.1.17.3 Recent developments
11.1.17.3.1 Product launches
11.1.18 HMS MEDICAL SYSTEMS
11.1.18.1 Business overview
11.1.18.2 Products offered
11.1.18.3 Recent developments
11.1.18.3.1 Product launches
11.1.19 ASTAR
11.1.19.1 Business overview
11.1.19.2 Products offered
11.1.20 EMBITRON S.R.O. (A CERTICON GROUP COMPANY)
11.1.20.1 Business overview
11.1.20.2 Products offered
11.1.20.3 Recent developments
11.1.20.3.1 Other developments
11.2 OTHER PLAYERS
11.2.1 PHYSIOMED ELEKTROMEDIZIN AG (FORMERLY PROXOMED)
11.2.2 TECNOBODY
11.2.3 COOLSYSTEMS, INC.
11.2.4 JOHARI DIGITAL
11.2.5 POWERMEDIC

12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS